These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19843900)

  • 1. Use of aldosterone antagonists in heart failure.
    Albert NM; Yancy CW; Liang L; Zhao X; Hernandez AF; Peterson ED; Cannon CP; Fonarow GC
    JAMA; 2009 Oct; 302(15):1658-65. PubMed ID: 19843900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction.
    Rassi AN; Cavender MA; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Rosas SE; Zhao X; Schwamm LH; Bhatt DL
    J Am Coll Cardiol; 2013 Jan; 61(1):35-40. PubMed ID: 23137936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure.
    Curtis LH; Mi X; Qualls LG; Check DK; Hammill BG; Hammill SC; Heidenreich PA; Masoudi FA; Setoguchi S; Hernandez AF; Fonarow GC
    Am Heart J; 2013 Jun; 165(6):979-986.e1. PubMed ID: 23708170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
    Shreibati JB; Sheng S; Fonarow GC; DeVore AD; Yancy CW; Bhatt DL; Schulte P; Peterson ED; Hernandez A; Heidenreich PA
    Am Heart J; 2016 Sep; 179():99-106. PubMed ID: 27595684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures.
    Allen LA; Fonarow GC; Liang L; Schulte PJ; Masoudi FA; Rumsfeld JS; Ho PM; Eapen ZJ; Hernandez AF; Heidenreich PA; Bhatt DL; Peterson ED; Krumholz HM;
    Circulation; 2015 Oct; 132(14):1347-53. PubMed ID: 26316616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of aldosterone antagonists at discharge after myocardial infarction: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get with the Guidelines (GWTG).
    Rao KK; Enriquez JR; de Lemos JA; Alexander KP; Chen AY; McGuire DK; Fonarow GC; Das SR
    Am Heart J; 2013 Oct; 166(4):709-15. PubMed ID: 24093851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between aldosterone antagonist therapy and risks of mortality and readmission among patients with heart failure and reduced ejection fraction.
    Hernandez AF; Mi X; Hammill BG; Hammill SC; Heidenreich PA; Masoudi FA; Qualls LG; Peterson ED; Fonarow GC; Curtis LH
    JAMA; 2012 Nov; 308(20):2097-107. PubMed ID: 23188026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and Safety of Aldosterone Antagonist Therapy Use Among Older Patients With Reduced Ejection Fraction After Acute Myocardial Infarction.
    Wang TY; Vora AN; Peng SA; Fonarow GC; Das S; de Lemos JA; Peterson ED
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
    Patel N; Ju C; Macon C; Thadani U; Schulte PJ; Hernandez AF; Bhatt DL; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 May; 4(5):348-56. PubMed ID: 26874392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee.
    Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC
    J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone antagonists and outcomes in real-world older patients with heart failure and preserved ejection fraction.
    Patel K; Fonarow GC; Kitzman DW; Aban IB; Love TE; Allman RM; Gheorghiade M; Ahmed A
    JACC Heart Fail; 2013 Feb; 1(1):40-7. PubMed ID: 23814702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure).
    Eschalier R; McMurray JJ; Swedberg K; van Veldhuisen DJ; Krum H; Pocock SJ; Shi H; Vincent J; Rossignol P; Zannad F; Pitt B;
    J Am Coll Cardiol; 2013 Oct; 62(17):1585-93. PubMed ID: 23810881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems: Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure.
    Maggioni AP; Van Gool K; Biondi N; Urso R; Klazinga N; Ferrari R; Maniadakis N; Tavazzi L
    Value Health; 2015 Dec; 18(8):1098-104. PubMed ID: 26686796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.
    Atwater BD; Dai D; Allen-Lapointe NM; Al-Khatib SM; Zimmer LO; Sanders GD; Peterson ED
    Am Heart J; 2012 Nov; 164(5):750-755.e1. PubMed ID: 23137506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the time of initiation of mineralocorticoid receptor antagonists on risk of mortality in patients with heart failure.
    Rossi R; Crupi N; Coppi F; Monopoli D; Sgura F
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):119-25. PubMed ID: 23539659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults: Get With The Guidelines-Heart Failure Registry.
    Diamond J; Ayodele I; Fonarow GC; Joynt-Maddox KE; Yeh RW; Hammond G; Allen LA; Greene SJ; Chiswell K; DeVore AD; Yancy C; Wadhera RK
    JAMA Cardiol; 2023 Jun; 8(6):545-553. PubMed ID: 37074702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure).
    Krantz MJ; Ambardekar AV; Kaltenbach L; Hernandez AF; Heidenreich PA; Fonarow GC;
    Am J Cardiol; 2011 Jun; 107(12):1818-23. PubMed ID: 21482418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.